SCHEMBL19017337

SCHEMBL19017337

CC(C)(/C=C(\C#N)C(=O)N1CCCC1)N1CCCC1

nearest known ligand 0.46

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.46
KDM4E B2RXH2 2/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
KMT2A Q03164 7/20 0.44
MEN1 O00255 4/20 0.44
GAA P10253 2/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
PKM P14618 1/20 0.40
NEK2 P51955 1/20 0.39
MAOB P27338 2/20 0.39
FTO Q9C0B1 1/20 0.36
EGFR P00533 1/20 0.35
GPX4 P36969 1/20 0.35
BTK Q06187 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20261599 0.98 ALDH1A1 (0.44) ALDH1A1KDM4EL3MBTL1KMT2AMEN1
SCHEMBL19017604 0.91 ALDH1A1 (0.43) ALDH1A1KDM4EL3MBTL1KMT2AMEN1
SCHEMBL32689936 0.90 ALDH1A1 (0.42) ALDH1A1KDM4EL3MBTL1KMT2AMEN1
SCHEMBL20082945 0.90 NPC1 (0.43) ALDH1A1KDM4EL3MBTL1KMT2AMEN1
SCHEMBL19017644 0.90 ALDH1A1 (0.43) ALDH1A1KDM4EL3MBTL1KMT2AMEN1
SCHEMBL19427238 0.89 NPC1 (0.42) ALDH1A1KDM4EL3MBTL1KMT2AMEN1
SCHEMBL20082951 0.85 ALDH1A1 (0.49) ALDH1A1KDM4EL3MBTL1KMT2AMEN1
SCHEMBL17065306 0.85 ALDH1A1 (0.49) ALDH1A1KDM4EL3MBTL1KMT2AMEN1
SCHEMBL19243861 0.84 ALDH1A1 (0.39) ALDH1A1KDM4EL3MBTL1KMT2AMEN1
SCHEMBL24243190 0.83 ALDH1A1 (0.48) ALDH1A1KDM4EL3MBTL1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3181567-B1 PYRAZOLOPYRIMIDINE COMPOUNDS AS KINASE INHIBITORS PRINCIPIA BIOPHARMA INC (US) 2019-03-20 EP disclosed
EP-3181567-A1 PYRAZOLOPYRIMIDINE COMPOUNDS AS KINASE INHIBITORS PRINCIPIA BIOPHARMA, INC. (US) 2017-06-21 EP disclosed